UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 457

Sortiert nach

Matrix Gla protein (MGP) and bone morphogenetic protein‐2 in aortic calcified lesions of aging rats

Journal of thrombosis and haemostasis, 2003-01, Vol.1 (1), p.178-185

2003

Volltextzugriff (PDF)

A molecular mechanism for genetic warfarin resistance in the rat

The FASEB journal, 2001-11, Vol.15 (13), p.2542-2544

2001

Volltextzugriff (PDF)

Matrix Gla protein synthesis and gamma-carboxylation in the aortic vessel wall and proliferating vascular smooth muscle cells--a cell system which resembles the system in bone cells

Thrombosis and haemostasis, 1999-12, Vol.82 (6), p.1764

1999

Volltextzugriff (PDF)

Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin

European journal of heart failure, 2003-08, Vol.5 (4), p.517-521

2003

Volltextzugriff (PDF)

Growth hormone increases regional coronary blood flow and capillary density in aged rats

The journals of gerontology. Series A, Biological sciences and medical sciences, 2001-08, Vol.56 (8), p.B364-B371

2001

Volltextzugriff (PDF)

The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats

The Journal of biological chemistry, 2004-06, Vol.279 (24), p.25276-25283

2004

Volltextzugriff (PDF)

Antibodies to tissue transglutaminase: an immune link between the gut, the coronaries and the myocardium?

Journal of internal medicine, 2008-01, Vol.263 (1), p.1-3

Sane, D. C.

2008

Volltextzugriff (PDF)

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention : Results of the gold (AU-assessing ultegra) multicenter study

Circulation (New York, N.Y.), 2001-05, Vol.103 (21), p.2572-2578

2001

Volltextzugriff (PDF)

Arterial calcification: A review of mechanisms, animal models, and the prospects for therapy

Medicinal research reviews, 2001-07, Vol.21 (4), p.274-301

2001

Volltextzugriff (PDF)

Cardiovascular implications of the factor V Leiden mutation

The American heart journal, 2000-08, Vol.140 (2), p.189-195

2000

Volltextzugriff (PDF)

Angiostatin binds to smooth muscle cells in the coronary artery and inhibits smooth muscle cell proliferation and migration In vitro

Arteriosclerosis, thrombosis, and vascular biology, 1999-09, Vol.19 (9), p.2041

1999

Volltextzugriff (PDF)

Production of plasminogen activator inhibitor‐1 (PAI‐1) by endothelial cells: differential responses to calcitriol and paricalcitol

Journal of thrombosis and haemostasis, 2004-12, Vol.2 (12), p.2266-2267

2004

Volltextzugriff (PDF)

Localization of a vitronectin binding region of plasminogen activator inhibitor-1

Thrombosis and haemostasis, 1995-05, Vol.73 (5), p.829

1995

Volltextzugriff (PDF)

Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management

Annals of internal medicine, 1989-12, Vol.111 (12), p.1010

1989

Volltextzugriff (PDF)

Upregulation of functional beta(3)-adrenergic receptor in the failing canine myocardium

Circulation research, 2001-09, Vol.89 (7), p.599-606

2001

Volltextzugriff (PDF)

Abciximab readministration: Results of the reopro readministration registry

Circulation (New York, N.Y.), 2001-08, Vol.104 (8), p.870-875

2001

Volltextzugriff (PDF)

A coumarin-based prodrug strategy to improve the oral absorption of RGD peptidomimetics

Journal of controlled release, 2000-03, Vol.65 (1), p.245-251

2000

Volltextzugriff (PDF)

Risk of bleeding complications with antiplatelet agents: Meta‐analysis of 338,191 patients enrolled in 50 randomized controlled trials

American journal of hematology, 2004-01, Vol.75 (1), p.40-47

2004

Volltextzugriff (PDF)

Anti-platelet factor 4/heparin antibodies: An independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes

Circulation (New York, N.Y.), 2003-05, Vol.107 (18), p.2307-2312

2003

Volltextzugriff (PDF)

Platelet aggregability in syndrome X: a role for adenosine

European heart journal, 2001-10, Vol.22 (20), p.1844-1845

2001

Volltextzugriff (PDF)

Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization

Journal of the American College of Cardiology, 1998-08, Vol.32 (2), p.311-319

1998

Volltextzugriff (PDF)

Clinical risks of thrombolytic therapy

The American journal of cardiology, 1992-01, Vol.69 (2), p.A12-A20

1992

Volltextzugriff (PDF)

Is time running out on streptokinase?

Journal of the American College of Cardiology, 1998-03, Vol.31 (4), p.780-782

1998

Volltextzugriff (PDF)

Localization of Tissue Transglutaminase in Human Carotid and Coronary Artery Atherosclerosis: Implications for Plaque Stability and Progression

Laboratory investigation, 2001-01, Vol.81 (1), p.83-93

2001

Volltextzugriff (PDF)

Magnitude and time course of platelet inhibition with Aggrenox® and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial

European journal of pharmacology, 2004-09, Vol.499 (3), p.315-324

2004

Volltextzugriff (PDF)

1 – 25 von 457

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(332)
Mit Volltextzugriff
(369)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Matrix Gla protein (MGP) and bone morphogenetic protein‐2 in aortic calcified lesions of aging rats

A molecular mechanism for genetic warfarin resistance in the rat

Matrix Gla protein synthesis and gamma-carboxylation in the aortic vessel wall and proliferating vascular smooth muscle cells--a cell system which resembles the system in bone cells

Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin

Growth hormone increases regional coronary blood flow and capillary density in aged rats

The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats

Antibodies to tissue transglutaminase: an immune link between the gut, the coronaries and the myocardium?

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention : Results of the gold (AU-assessing ultegra) multicenter study

Arterial calcification: A review of mechanisms, animal models, and the prospects for therapy

Cardiovascular implications of the factor V Leiden mutation

Angiostatin binds to smooth muscle cells in the coronary artery and inhibits smooth muscle cell proliferation and migration In vitro

Production of plasminogen activator inhibitor‐1 (PAI‐1) by endothelial cells: differential responses to calcitriol and paricalcitol

Localization of a vitronectin binding region of plasminogen activator inhibitor-1

Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management

Upregulation of functional beta(3)-adrenergic receptor in the failing canine myocardium

Abciximab readministration: Results of the reopro readministration registry

A coumarin-based prodrug strategy to improve the oral absorption of RGD peptidomimetics

Risk of bleeding complications with antiplatelet agents: Meta‐analysis of 338,191 patients enrolled in 50 randomized controlled trials

Anti-platelet factor 4/heparin antibodies: An independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes

Platelet aggregability in syndrome X: a role for adenosine

Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization

Clinical risks of thrombolytic therapy

Is time running out on streptokinase?

Localization of Tissue Transglutaminase in Human Carotid and Coronary Artery Atherosclerosis: Implications for Plaque Stability and Progression

Magnitude and time course of platelet inhibition with Aggrenox® and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial

Suchergebnisse filtern